Latest Breaking News On - Accuredit therapeutics - Page 1 : comparemela.com

Eli Lilly penned a $258 million R&D pact with Abbisko Therapeutics. Daiichi Sankyo sold U.S. cardiovascular drugs to Cosette Pharma. Eisai's neurology chief talked about its Aduhelm follow-on drug. And more.

Ridgeback biotherapeuticIvan cheungDaiichi sankyoEli lillyKen kellerBayer nexavarFosun pharmaMerck coStanford universityAbbisko therapeuticsCosette pharmaFierce biotechBiogen partnered alzheimerAccuredit therapeuticsUnited nations backed medicines patent poolDaiichi sankyo